Cargando…
1866. Can β-lactam Combinations Restore Susceptibility Against Mycobacterium avium Complex: Exploring a New Approach to a “Difficult to Treat” Opportunistic Pathogen
BACKGROUND: Mycobacterium avium Complex (MAC) are nontuberculous mycobacteria (NTM) responsible for chronic and debilitating diseases, with rising global prevalence. Clinical relapse/reinfection rates of MAC following treatment with first-line therapies range from 25% to 45%. β-lactam antibiotics ar...
Autores principales: | Al-Jabri, Maha Y, Dousa, Khalid M, Wilson, Brigid, Holland, Steven M, Bonomo, Robert A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678549/ http://dx.doi.org/10.1093/ofid/ofad500.1694 |
Ejemplares similares
-
Eradicating Pulmonary Mycobacterium abscessus: The Promise of Dual β-Lactam Therapy
por: Alahmdi, Bayan, et al.
Publicado: (2023) -
General Overview of Nontuberculous Mycobacteria Opportunistic Pathogens: Mycobacterium avium and Mycobacterium abscessus
por: To, Kimberly, et al.
Publicado: (2020) -
1642. A Novel β-lactamase Inhibitor (Durlobactam, DUR) and β-Lactams Enhance Susceptibility Against Multidrug-Resistant (MDR) Mycobacterium abscessus (Mab)
por: Dousa, Khalid M, et al.
Publicado: (2020) -
The recombination-cold region as an epidemiological marker of recombinogenic opportunistic pathogen Mycobacterium avium
por: Yano, Hirokazu, et al.
Publicado: (2019) -
Opportunistic Pathogens Mycobacterium Avium Complex (MAC) and Legionella spp. Colonise Model Shower
por: Whiley, Harriet, et al.
Publicado: (2015)